Marcel Frenkel
Signal active
Founder and CEO
Contact Information
Social
Primary Organization
Ten63 Therapeutics
Founded
2017
Employees
11-50
Industry
Biotechnology, Health Care, Pharmaceutical, Medical
Bio
Marcel Frenkel serves as a founder and CEO at Ten63 Therapeutics. He attended the University of Notre Dame.
Location
Chapel Hill, North Carolina, United States, North America
Jobs history
1
Ten63 Therapeutics
Founder and CEO
2019 - Current
Educations
2
University of Notre Dame
Biochemistry
University of Notre Dame
Film Theatre and film and biochemistry double
Profile Resume
Marcel Frenkel is the Founder and CEO at Ten63 Therapeutics, based in United States, North America. With a background in Biotechnology, Marcel Frenkel has a rich history of leadership and innovation.Marcel Frenkel studied BS Biochemistry at University of Notre Dame. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.